Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight
ItalyStudy on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension
ItalyStudy on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment
ItalyStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
ItalyStudy of M9140 for Patients with Advanced Non-Small Cell Lung Cancer
ItalyStudy of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations
ItalyStudy of M9140 for Patients with Advanced Stomach Cancer
ItalyStudy on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients
ItalyStudy Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
ItalyStudy of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment
ItalyStudy Comparing Oral Fluoroquinolones or Trimethoprim-Sulfamethoxazole to IV Therapy in Stable Patients with Gram-Negative Blood Infections
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
